CRISPR Trials Are About to Begin in People–But We Still Don’t Know How Well It Works in Monkeys

April 12, 2018

(MIT Technology Review) – Sometime this year, people in the US and Europe will start getting treated for diseases using the gene-editing tool CRISPR, but a big question remains—will it actually work? Our primate cousins may hold the answer. The first use of CRISPR to edit human cells in a dish was reported in 2013. It’s since been touted as an easy way to alter people’s DNA, promising to banish what are currently lethal or lifelong maladies with a single treatment that fixes them at the genetic root.

Recommended Reading